Genetic and epigenetic contributors to FSHD

Current Opinion in Genetics and Development

Volumn 33, Issue , 2015, Pages 56-61

  Daxinger, Lucia ^a   Tapscott, Stephen J ^b   van der Maarel, Silvère M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; CHROMATIN; DUX4 PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; MICROSATELLITE DNA; NONHISTONE PROTEIN; SMCHD1 PROTEIN, HUMAN;

ALLELE; CHROMATIN; D4Z4 GENE; DNA METHYLATION; DUX4 GENE; EPIGENETICS; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; GENE; GENE EXPRESSION; GENE MUTATION; GENE SILENCING; GENETICS; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE; SMCHD1 GENE; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; PATHOLOGY;

ALLELES; CHROMATIN; CHROMOSOMAL PROTEINS, NON-HISTONE; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; HOMEODOMAIN PROTEINS; HUMANS; MICROSATELLITE REPEATS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL;

EID: 84941049530     PISSN: 0959437X     EISSN: 18790380     Source Type: Journal    
DOI: 10.1016/j.gde.2015.08.007     Document Type: Review

References (53)

1. Padberg G.W., Lunt P.W., Koch M., Fardeau M. Diagnostic criteria for facioscapulohumeral muscular dystrophy. Neuromuscul Disord 1991, 1:231-234.
2. van Deutekom J.C., Wijmenga C., van Tienhoven E.A., Gruter A.M., Hewitt J.E., Padberg G.W., van Ommen G.J., Hofker M.H., Frants R.R. FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2kb tandemly repeated unit. Hum Mol Genet 1993, 2:2037-2042.
3. Wijmenga C., Hewitt J.E., Sandkuijl L.A., Clark L.N., Wright T.J., Dauwerse H.G., Gruter A.M., Hofker M.H., Moerer P., Williamson R., et al. Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy. Nat Genet 1992, 2:26-30.
4. Lemmers R.J., de Kievit P., Sandkuijl L., Padberg G.W., van Ommen G.J., Frants R.R., van der Maarel S.M. Facioscapulohumeral muscular dystrophy is uniquely associated with one of the two variants of the 4q subtelomere. Nat Genet 2002, 32:235-236.
5. Lemmers R.J., Tawil R., Petek L.M., Balog J., Block G.J., Santen G.W., Amell A.M., van der Vliet P.J., Almomani R., Straasheijm K.R., et al. Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2. Nat Genet 2012, 44:1370-1374.
6. van Overveld P.G., Lemmers R.J., Sandkuijl L.A., Enthoven L., Winokur S.T., Bakels F., Padberg G.W., van Ommen G.J., Frants R.R., van der Maarel S.M. Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy. Nat Genet 2003, 35:315-317.
7. Zeng W., de Greef J.C., Chen Y.Y., Chien R., Kong X., Gregson H.C., Winokur S.T., Pyle A., Robertson K.D., Schmiesing J.A., et al. Specific loss of histone H3 lysine 9 trimethylation and HP1gamma/cohesin binding at D4Z4 repeats is associated with facioscapulohumeral dystrophy (FSHD). PLoS Genet 2009, 5:e1000559.
8. Snider L., Geng L.N., Lemmers R.J., Kyba M., Ware C.B., Nelson A.M., Tawil R., Filippova G.N., van der Maarel S.M., Tapscott S.J., et al. Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene. PLoS Genet 2010, 6:e1001181.
9. Lemmers R.J., van der Vliet P.J., Klooster R., Sacconi S., Camano P., Dauwerse J.G., Snider L., Straasheijm K.R., van Ommen G.J., Padberg G.W., et al. A unifying genetic model for facioscapulohumeral muscular dystrophy. Science 2010, 329:1650-1653.
10. Balog J., Thijssen P.E., de Greef J.C., Shah B., van Engelen B.G., Yokomori K., Tapscott S.J., Tawil R., van der Maarel S.M. Correlation analysis of clinical parameters with epigenetic modifications in the DUX4 promoter in FSHD. Epigenetics 2012, 7:579-584.
11. Deidda G., Cacurri S., Grisanti P., Vigneti E., Piazzo N., Felicetti L. Physical mapping evidence for a duplicated region on chromosome 10qter showing high homology with the facioscapulohumeral muscular dystrophy locus on chromosome 4qter. Eur J Hum Genet 1995, 3:155-167.
12. Hewitt J.E., Lyle R., Clark L.N., Valleley E.M., Wright T.J., Wijmenga C., van Deutekom J.C., Francis F., Sharpe P.T., Hofker M., et al. Analysis of the tandem repeat locus D4Z4 associated with facioscapulohumeral muscular dystrophy. Hum Mol Genet 1994, 3:1287-1295.
13. Gabriels J., Beckers M.C., Ding H., De Vriese A., Plaisance S., van der Maarel S.M., Padberg G.W., Frants R.R., Hewitt J.E., Collen D., et al. Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3kb element. Gene 1999, 236:25-32.
14. Leidenroth A., Hewitt J.E. A family history of DUX4: phylogenetic analysis of DUXA, B, C and Duxbl reveals the ancestral DUX gene. BMC Evol Biol 2010, 10:364.
15. Lemmers R.J., Van Overveld P.G., Sandkuijl L.A., Vrieling H., Padberg G.W., Frants R.R., van der Maarel S.M. Mechanism and timing of mitotic rearrangements in the subtelomeric D4Z4 repeat involved in facioscapulohumeral muscular dystrophy. Am J Hum Genet 2004, 75:44-53.
16. Cabianca D.S., Casa V., Bodega B., Xynos A., Ginelli E., Tanaka Y., Gabellini D. A long ncRNA links copy number variation to a polycomb/trithorax epigenetic switch in FSHD muscular dystrophy. Cell 2012, 149:819-831.
17. Lemmers R.J., van der Vliet P.J., van der Gaag K.J., Zuniga S., Frants R.R., de Knijff P., van der Maarel S.M. Worldwide population analysis of the 4q and 10q subtelomeres identifies only four discrete interchromosomal sequence transfers in human evolution. Am J Hum Genet 2010, 86:364-377.
18. Scionti I., Greco F., Ricci G., Govi M., Arashiro P., Vercelli L., Berardinelli A., Angelini C., Antonini G., Cao M., et al. Large-scale population analysis challenges the current criteria for the molecular diagnosis of fascioscapulohumeral muscular dystrophy. Am J Hum Genet 2012, 90:628-635.
19. Lemmers R.J., Goeman J.J., van der Vliet P.J., van Nieuwenhuizen M.P., Balog J., Vos-Versteeg M., Camano P., Ramos Arroyo M.A., Jerico I., Rogers M.T., et al. Inter-individual differences in CpG methylation at D4Z4 correlate with clinical variability in FSHD1 and FSHD2. Hum Mol Genet 2015, 24:659-669.
20. Tupler R., Berardinelli A., Barbierato L., Frants R., Hewitt J.E., Lanzi G., Maraschio P., Tiepolo L. Monosomy of distal 4q does not cause facioscapulohumeral muscular dystrophy. J Med Genet 1996, 33:366-370.
21. Dixit M., Ansseau E., Tassin A., Winokur S., Shi R., Qian H., Sauvage S., Matteotti C., van Acker A.M., Leo O., et al. DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1. Proc Natl Acad Sci U S A 2007, 104:18157-18162.
22. Kowaljow V., Marcowycz A., Ansseau E., Conde C.B., Sauvage S., Matteotti C., Arias C., Corona E.D., Nunez N.G., Leo O., et al. The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein. Neuromuscul Disord 2007, 17:611-623.
23. Vanderplanck C., Ansseau E., Charron S., Stricwant N., Tassin A., Laoudj-Chenivesse D., Wilton S.D., Coppee F., Belayew A. The FSHD atrophic myotube phenotype is caused by DUX4 expression. PLoS ONE 2011, 6:e26820.
24. Wallace L.M., Garwick S.E., Mei W., Belayew A., Coppee F., Ladner K.J., Guttridge D., Yang J., Harper S.Q. DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53-dependent myopathy in vivo. Ann Neurol 2011, 69:540-552.
25. Mitsuhashi H., Mitsuhashi S., Lynn-Jones T., Kawahara G., Kunkel L.M. Expression of DUX4 in zebrafish development recapitulates facioscapulohumeral muscular dystrophy. Hum Mol Genet 2013, 22:568-577.
26. Geng L.N., Yao Z., Snider L., Fong A.P., Cech J.N., Young J.M., van der Maarel S.M., Ruzzo W.L., Gentleman R.C., Tawil R., et al. DUX4 activates germline genes, retroelements, and immune mediators: implications for facioscapulohumeral dystrophy. Dev Cell 2012, 22:38-51.
27. Young J.M., Whiddon J.L., Yao Z., Kasinathan B., Snider L., Geng L.N., Balog J., Tawil R., van der Maarel S.M., Tapscott S.J. DUX4 binding to retroelements creates promoters that are active in FSHD muscle and testis. PLoS Genet 2013, 9:e1003947.
28. Sharma V., Harafuji N., Belayew A., Chen Y.W. DUX4 differentially regulates transcriptomes of human rhabdomyosarcoma and mouse C2C12 cells. PLoS ONE 2013, 8:e64691.
29. Feng Q., Snider L., Jagannathan S., Tawil R., van der Maarel S.M., Tapscott S.J., Bradley R.K. A feedback loop between nonsense-mediated decay and the retrogene DUX4 in facioscapulohumeral muscular dystrophy. Elife 2015, 4.
30. Ferreboeuf M., Mariot V., Bessieres B., Vasiljevic A., Attie-Bitach T., Collardeau S., Morere J., Roche S., Magdinier F., Robin-Ducellier J., et al. DUX4 and DUX4 downstream target genes are expressed in fetal FSHD muscles. Hum Mol Genet 2014, 23:171-181.
31. Tassin A., Laoudj-Chenivesse D., Vanderplanck C., Barro M., Charron S., Ansseau E., Chen Y.W., Mercier J., Coppee F., Belayew A. DUX4 expression in FSHD muscle cells: how could such a rare protein cause a myopathy?. J Cell Mol Med 2013, 17:76-89.
32. de Greef J.C., Lemmers R.J., Camano P., Day J.W., Sacconi S., Dunand M., van Engelen B.G., Kiuru-Enari S., Padberg G.W., Rosa A.L., et al. Clinical features of facioscapulohumeral muscular dystrophy 2. Neurology 2010, 75:1548-1554.
33. Sacconi S., Lemmers R.J., Balog J., van der Vliet P.J., Lahaut P., van Nieuwenhuizen M.P., Straasheijm K.R., Debipersad R.D., Vos-Versteeg M., Salviati L., et al. The FSHD2 gene SMCHD1 is a modifier of disease severity in families affected by FSHD1. Am J Hum Genet 2013, 93:744-751.
34. Mitsuhashi S., Boyden S.E., Estrella E.A., Jones T.I., Rahimov F., Yu T.W., Darras B.T., Amato A.A., Folkerth R.D., Jones P.L., et al. Exome sequencing identifies a novel SMCHD1 mutation in facioscapulohumeral muscular dystrophy 2. Neuromuscul Disord 2013, 23:975-980.
35. Winston J., Duerden L., Mort M., Frayling I.M., Rogers M.T., Upadhyaya M. Identification of two novel SMCHD1 sequence variants in families with FSHD-like muscular dystrophy. Eur J Hum Genet 2015, 23:67-71.
36. Larsen M., Rost S., El Hajj N., Ferbert A., Deschauer M., Walter M.C., Schoser B., Tacik P., Kress W., Muller C.R. Diagnostic approach for FSHD revisited: SMCHD1 mutations cause FSHD2 and act as modifiers of disease severity in FSHD1. Eur J Hum Genet 2014.
37. van den Boogaard M.L., Jfl Lemmers R., Camano P., van der Vliet P.J., Voermans N., van Engelen B.G., de Munain A.L., Tapscott S.J., van der Stoep N., Tawil R., et al. Double SMCHD1 variants in FSHD2: the synergistic effect of two SMCHD1 variants on D4Z4 hypomethylation and disease penetrance in FSHD2. Eur J Hum Genet 2015.
38. Lemmers R.J., van den Boogaard M.L., van der Vliet P.J., Donlin-Smith C.M., Nations S.P., Ruivenkamp C.A., Heard P., Bakker B., Tapscott S., Cody J.D., et al. Hemizygosity for SMCHD1 in facioscapulohumeral muscular dystrophy type 2: consequences for 18p deletion syndrome. Hum Mutat 2015.
39. Tawil R., van der Maarel S.M., Tapscott S.J. Facioscapulohumeral dystrophy: the path to consensus on pathophysiology. Skelet Muscle 2014, 4:12.
40. Blewitt M.E., Gendrel A.V., Pang Z., Sparrow D.B., Whitelaw N., Craig J.M., Apedaile A., Hilton D.J., Dunwoodie S.L., Brockdorff N., et al. SmcHD1, containing a structural-maintenance-of-chromosomes hinge domain, has a critical role in X inactivation. Nat Genet 2008, 40:663-669.
41. Gendrel A.V., Apedaile A., Coker H., Termanis A., Zvetkova I., Godwin J., Tang Y.A., Huntley D., Montana G., Taylor S., et al. Smchd1-dependent and -independent pathways determine developmental dynamics of CpG island methylation on the inactive X chromosome. Dev Cell 2012, 23:265-279.
42. Mould A.W., Pang Z., Pakusch M., Tonks I.D., Stark M., Carrie D., Mukhopadhyay P., Seidel A., Ellis J.J., Deakin J., et al. Smchd1 regulates a subset of autosomal genes subject to monoallelic expression in addition to being critical for X inactivation. Epigenet Chromatin 2013, 6:19.
43. Gendrel A.V., Tang Y.A., Suzuki M., Godwin J., Nesterova T.B., Greally J.M., Heard E., Brockdorff N. Epigenetic functions of Smchd1 repress gene clusters on the inactive X chromosome and on autosomes. Mol Cell Biol 2013, 33:3150-3165.
44. Grolimund L., Aeby E., Hamelin R., Armand F., Chiappe D., Moniatte M., Lingner J. A quantitative telomeric chromatin isolation protocol identifies different telomeric states. Nat Commun 2013, 4:2848.
45. Dejardin J., Kingston R.E. Purification of proteins associated with specific genomic Loci. Cell 2009, 136:175-186.
46. Statland J.M., Tawil R. Facioscapulohumeral muscular dystrophy: molecular pathological advances and future directions. Curr Opin Neurol 2011, 24:423-428.
47. Padberg G.W. Thesis: facioscapulohumeral disease 1982, Leiden University, https://openaccess.leidenuniv.nl/handle/1887/25818.
48. Tawil R., Forrester J., Griggs R.C., Mendell J., Kissel J., McDermott M., King W., Weiffenbach B., Figlewicz D. Evidence for anticipation and association of deletion size with severity in facioscapulohumeral muscular dystrophy. The FSH-DY Group. Ann Neurol 1996, 39:744-748.
49. Ricci E., Galluzzi G., Deidda G., Cacurri S., Colantoni L., Merico B., Piazzo N., Servidei S., Vigneti E., Pasceri V., et al. Progress in the molecular diagnosis of facioscapulohumeral muscular dystrophy and correlation between the number of KpnI repeats at the 4q35 locus and clinical phenotype. Ann Neurol 1999, 45:751-757.
50. Lunt P.W., Jardine P.E., Koch M., Maynard J., Osborn M., Williams M., Harper P.S., Upadhyaya M. Phenotypic-genotypic correlation will assist genetic counseling in 4q35-facioscapulohumeral muscular dystrophy. Muscle Nerve 1995, Suppl:S103-S109.
51. Goto K., Lee J.H., Matsuda C., Hirabayashi K., Kojo T., Nakamura A., Mitsunaga Y., Furukawa T., Sahashi K., Arahata K. DNA rearrangements in Japanese facioscapulohumeral muscular dystrophy patients: clinical correlations. Neuromuscul Disord 1995, 5:201-208.
52. Jones T.I., Yan C., Sapp P.C., McKenna-Yasek D., Kang P.B., Quinn C., Salameh J.S., King O.D., Jones P.L. Identifying diagnostic DNA methylation profiles for facioscapulohumeral muscular dystrophy in blood and saliva using bisulfite sequencing. Clin Epigenet 2014, 6:23.
53. Gaillard M.C., Roche S., Dion C., Tasmadjian A., Bouget G., Salort-Campana E., Vovan C., Chaix C., Broucqsault N., Morere J., et al. Differential DNA methylation of the D4Z4 repeat in patients with FSHD and asymptomatic carriers. Neurology 2014, 83:733-742.